Αποτελέσματα Αναζήτησης
30 Δεκ 2020 · The mRNA-1273 vaccine is a lipid nanoparticle–encapsulated mRNA-based vaccine that encodes the prefusion stabilized full-length spike protein of the severe acute respiratory syndrome...
31 Αυγ 2022 · Challenges facing the Covid-19 vaccine field include inequitable vaccine distribution, vaccine hesitancy, waning immunity, and the emergence of highly transmissible viral variants that...
10 Μαρ 2022 · The rapid production and clinical development of efficacious vaccines to mitigate the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has been a testament to decades of research and sequential advances in immunology, vaccinology, and adjuvant biology.
22 Μαρ 2024 · The rapid development and deployment of effective COVID-19 vaccines has been a triumph of biomedical research and has dramatically reduced the overall clinical severity of SARS-CoV-2 infection among vaccinees.
10 Φεβ 2023 · We found that the vaccine effectiveness of the primary vaccine series against SARS-CoV-2 infections begins at an adequate level, as defined by WHO, of 83% at 14–42 days after series completion; however, vaccine effectiveness decreased significantly by 112 days after vaccination, reaching 47% by 280 days after vaccination, well below an ...
17 Ιουλ 2024 · New infections with SARS-CoV-2 continue 4 years after the pandemic began, despite advances in vaccines, antiviral medications, and preventive measures. 1 Beyond the serious complications of...
20 Ιαν 2022 · Analysis of COVID-19 vaccination status was adjusted for ever having tested positive for SARS-CoV-2, and analysis of SARS-CoV-2 infection was adjusted for COVID-19 vaccination. c Propensity scores were developed to predict the odds of vaccination.
